Dynamic Borrowing in Early Development Oncology

dynamic borrowing
oncology
Rare disease phase 2 with ps-augmented survival

In a rare oncology indication, we planned a small trial and augmented the results with external control data to aid in decision making for the continued development.

Methods Introduction

Code

print(1:10)
 [1]  1  2  3  4  5  6  7  8  9 10

References